Command Palette

Search for a command to run...

JBCHEPHARM
1667.6(-0.34%)
1W: -2.13%

JB Chemicals & Pharmaceuticals Peer Comparison

Snapshot Summary

JB Chemicals & Pharmaceuticals Ltd. showcases strong growth and profitability metrics relative to its peers. While it exhibits a competitive ROE and revenue growth, it is also well-positioned in terms of valuation, making it a compelling choice in the pharmaceuticals sector. Companies like Cipla and Dr. Reddy's also stand out for their strong profitability, while others like Divi's Laboratories face challenges despite high valuations.

  • JB Chemicals has robust revenue growth of 10.63% YoY and a healthy ROE of 21.49%.
  • Cipla and Dr. Reddy's are notable for their strong profitability metrics with attractive PE ratios.
  • Divi's Laboratories is facing significant declines in revenue growth despite high valuations.
  • Cipla Ltd.: High profitability metrics with a PE of 23.73 and solid revenue growth of 13.28% YoY.
  • Dr. Reddy's Laboratories Ltd.: Strong profitability with a low PE of 15.50 and substantial revenue growth of 16.54% YoY.
  • JB Chemicals & Pharmaceuticals Ltd.: Competitive growth and profitability metrics with a PE of 41.33 and revenue growth of 10.63% YoY.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
JBCHEPHARM₹1,724.45₹26,845.72Cr41.3325.23%0.13
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.